AcrySof ® IQ Vivity ® complements Alcon's existing intraocular portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens ...

An angle-supported phakic IOL remained stable in the anterior segment after pupil dilation, a study found. The AcrySof Cachet pIOL (Alcon) has proven safe and effective in previous studies, the ...

Antonio Toso PARIS — Aberrometric analysis of highly myopic eyes implanted with the AcrySof Cachet angle-supported phakic IOL showed improvement in point spread function and visual quality. "We ...

AcrySof ® IQ Vivity ®, a non-diffractive IOL, uses Alcon’s proprietary Wavefront-Shaping X-WAVE TM technology, a next-generation optical principle that stretches and shifts light without ...

May 3, 2012 (Chicago, Illinois) — Four- and 5-year data from second-eye implantation of the AcrySof Cachet phakic lens reveal stable and predictable refractive outcomes with excellent visual ...

The AcrySof (R) ReSTOR (R) lens is a foldable IOL that represents breakthrough technology because of its unique, patented optic design, which allows patients to experience the highest level of ...

In today’s Your Health Matters, Dr. Jeffrey Horn of Vision for Life talks about The AcrySof® IQ Vivity™ Lens and how it's giving patients a renewed outlook on life.

The AcrySof SA60TT toric series of IOLs (Alcon, Switzerland) is made of hydrophobic Acrylate and shares the same biconvex single-piece design as the AcrySof SA60AT monofocal IOL (Alcon, Switzerland).

Her right eye was implanted with the Acrysof Cachet Phakic IOL on June 22 last year. The left eye followed after three days. She is now free from her glasses and contact lenses.

The AcrySof (R) IQ IOL is an aspheric lens that is designed to reduce spherical aberration and has been shown to improve night driving performance versus a conventional spherical IOL.

Correspondence Published: 07 November 2008 Reversed vaulted AcrySof intraocular lens presenting as pupillary block S Harsum & S Low Eye 23, 1880–1882 (2009) Cite this article ...